Multiple System Atrophy

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf neurodegenerative disease
gptkbp:abbreviation gptkb:MSA
gptkbp:affects movement
autonomic nervous system
gptkbp:cause unknown
gptkbp:diagnosedBy clinical evaluation
MRI
autonomic testing
gptkbp:firstDescribed 1969
gptkbp:frequency rare
gptkbp:gender slightly more common in men
gptkbp:hasNoCure true
gptkbp:hasOrphanetID gptkb:ORPHA102
https://www.w3.org/2000/01/rdf-schema#label Multiple System Atrophy
gptkbp:ICD-10_code G90.3
gptkbp:inheritance sporadic
gptkbp:medianSurvival 6 to 10 years
gptkbp:MeSH_ID D020754
gptkbp:MSA-C cerebellar type
gptkbp:MSA-P parkinsonian type
gptkbp:notableContributor gptkb:Graham_and_Oppenheimer
gptkbp:OMIM 146500
gptkbp:onset adult
50s to 60s
gptkbp:pathology alpha-synuclein accumulation
glial cytoplasmic inclusions
gptkbp:prevalence 3 to 5 per 100,000
gptkbp:prognosis progressive
poor
gptkbp:relatedTo gptkb:Shy-Drager_syndrome
gptkb:olivopontocerebellar_atrophy
gptkb:Parkinson's_disease
gptkb:striatonigral_degeneration
gptkbp:riskFactor age over 50
gptkbp:subspecies gptkb:MSA-C
gptkb:MSA-P
gptkbp:symptom gptkb:orthostatic_hypotension
bradykinesia
tremor
autonomic dysfunction
erectile dysfunction
parkinsonism
urinary incontinence
muscle rigidity
cerebellar ataxia
gptkbp:treatment physical therapy
symptomatic management
medications for blood pressure
medications for parkinsonism
gptkbp:bfsParent gptkb:Atypical_Parkinsonian_Syndromes
gptkbp:bfsLayer 6